BY
Bhavna Yash Sanghavi
About Bhavna Yash Sanghavi
Data last updated:
Bhavna Yash Sanghavi is a Director at Satyan Pharmaceuticals Private Limited (since 1986) and Director at Regrow Biosciences Private Limited (since 1989). The 2 current companies with reported revenue have a combined latest revenue of ₹90.45 Cr; the largest is Satyan Pharmaceuticals Private Limited at ₹75.93 Cr (FY 2025). Earlier, Bhavna Yash Sanghavi was a Director at Satyan Finance And Investments Limited (1995–2016).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Satyan Pharmaceuticals Private Limited U24230MH1986PTC041306 | Director | 21 Oct 1986 | 1986 | ₹75.93 Cr (FY 2025) | Active |
 Regrow Biosciences Private Limited U24100MH1989PTC054162 | Director | 06 Nov 1989 | 1989 | ₹14.52 Cr (FY 2025) | Active |
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Satyan Finance And Investments Limited U65990MH1995PLC093661 | Director | 16 Oct 1995 | 1995 | ₹45,910 (FY 2024) | Active |
Explore Director's current and past company associations Uncover their professional journey today!
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Bhavna Yash Sanghavi
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Bhavna Yash Sanghavi
Bhavna Yash Sanghavi currently holds 2 directorships: Satyan Pharmaceuticals Private Limited (Director, since 21 Oct 1986, revenue ₹75.93 Cr (FY 2025)); Regrow Biosciences Private Limited (Director, since 06 Nov 1989, revenue ₹14.52 Cr (FY 2025)).
Bhavna Yash Sanghavi was first appointed on 21 Oct 1986 as Director at Satyan Pharmaceuticals Private Limited. The most recent appointment on record is 16 Oct 1995 at Satyan Finance And Investments Limited.
The 2 current companies of Bhavna Yash Sanghavi that report revenue have a combined latest revenue of ₹90.45 Cr: Satyan Pharmaceuticals Private Limited ₹75.93 Cr (FY 2025); Regrow Biosciences Private Limited ₹14.52 Cr (FY 2025).
Bhavna Yash Sanghavi held 1 earlier board appointment: Satyan Finance And Investments Limited (Director, 16 Oct 1995 to 28 Jun 2016).